| Date | Time | Source | Headline | Symbol | Company |
| 07/16/2024 | 9:34AM | Business Wire | Business Development Veteran Henry Hagenbuch Joins Lido Advisors as Senior Managing Director for M&A | | |
| 07/16/2024 | 9:33AM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:IP | International Paper Company |
| 07/16/2024 | 9:33AM | Business Wire | Fuding White Tea: A Chinese Treasure Showcased in Paris | | |
| 07/16/2024 | 9:33AM | PR Newswire (US) | Entrepreneurs' Organization Baltimore Honored with Maryland Inno Fire Awards 2024 | | |
| 07/16/2024 | 9:32AM | Alliance News |  US retail sales flat in June from May but higher on year before | | |
| 07/16/2024 | 9:32AM | GlobeNewswire Inc. | Andan Foundation Announces Award for Innovation in Refugee Inclusion in Collaboration with the Massachusetts Institute of Technology’s MIT Solve | | |
| 07/16/2024 | 9:32AM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:PGR | Progressive Corporation |
| 07/16/2024 | 9:32AM | PR Newswire (US) | MOCA Systems Launches MOCA911 Service for At-Risk Commercial Construction Projects | | |
| 07/16/2024 | 9:32AM | PR Newswire (US) | Botrista Reaches $120 Million in Total Fundraising, Enhances Beverage AI Tools | | |
| 07/16/2024 | 9:30AM | PR Newswire (US) | INNVENTURES' GROWTH CONTINUES WITH TWO NEW MANAGEMENT CONTRACTS | | |
| 07/16/2024 | 9:30AM | Business Wire | Tempus Expands Immuno-Oncology Portfolio with Launch of AI-enabled, Multimodal Immune Profile Algorithmic Tests | NASDAQ:TEM | Tempus AI Inc |
| 07/16/2024 | 9:30AM | Business Wire | Perry J. Sternberg Joins Sydnexis as Chief Executive Officer | | |
| 07/16/2024 | 9:30AM | Business Wire | Emplifi Named a Winner in Info-Tech Research Group’s Emotional Footprint Awards Two Years Running | | |
| 07/16/2024 | 9:30AM | GlobeNewswire Inc. | Bollinger Motors Names Former GM Executive James Taylor as CEO, Promotes Bryan Chambers to President & COO, Siva Kumar to Chief Strategy Officer | NASDAQ:MULN | Mullen Automotive Inc |
| 07/16/2024 | 9:30AM | PR Newswire (US) | Former Departmental CSO of Eli Lilly Joins Envisagenics Board of Directors | | |
| 07/16/2024 | 9:30AM | PR Newswire (US) | Leopard Solutions Releases New Whitepaper: Diversity in Big Law: Aspirations, Challenges, and the Path Forward | | |
| 07/16/2024 | 9:30AM | PR Newswire (US) | NCICU Receives $1.3M Grant to Partner with NCCCS to Streamline Transfer Pathways | | |
| 07/16/2024 | 9:30AM | PR Newswire (US) | Veteran Wealth Advisor Kara S. Boccella, Consistently Ranked Among Forbes' Top Women Wealth Advisors in State Rankings, and $1.2B AUM Team Launch Serenus Wealth Advisors | | |
| 07/16/2024 | 9:30AM | PR Newswire (US) | Fitness International Acquires XSport Fitness, expanding presence in Chicagoland, New York and Virginia markets | | |
| 07/16/2024 | 9:30AM | PR Newswire (US) | New Research Supports Continuous GLP-1 Use During Endoscopic Procedures | | |
| 07/16/2024 | 9:30AM | PR Newswire (US) | Q3 TD Cowen/AFS Freight Index: How stagnant demand plays out across truckload, parcel and LTL | | |
| 07/16/2024 | 9:28AM | GlobeNewswire Inc. | Performance Shipping Inc. Secures Sale and Leaseback Agreement for Previously Announced Newbuild LR2 Aframax Tanker | NASDAQ:PSHG | Performance Shipping Inc |
| 07/16/2024 | 9:28AM | GlobeNewswire Inc. | LuxUrban Hotels Announces Closing of Public Offering of Securities | NASDAQ:LUXH | LuxUrban Hotels Inc |
| 07/16/2024 | 9:28AM | PR Newswire (US) | Maison Louis Latour Selects 360's Three Cheers for U.S. PR Duties | | |
| 07/16/2024 | 9:27AM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:PGR | Progressive Corporation |
| 07/16/2024 | 9:27AM | Business Wire | Wolters Kluwer named Premier Leader in BPM Partners Vendor Landscape Matrix for second consecutive year | | |
| 07/16/2024 | 9:26AM | GlobeNewswire Inc. | Rascals Wins “Training Diaper Product of the Year” In 2024 Baby Innovation Awards | | |
| 07/16/2024 | 9:26AM | GlobeNewswire Inc. | Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis | | |
| 07/16/2024 | 9:26AM | PR Newswire (US) | Athletes' health - effects of environmental pollutants and nutrition on epithelial barrier function and healthy microbes in the body | | |
| 07/16/2024 | 9:25AM | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NYSE:CMU | MFS High Yield Municipal Trust |